Monashee Investment Management LLC
Position in ENGN — enGene Therapeutics Inc.
CIK 1627608
Boston, MA
Position in ENGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,179,200
-$484,650 QoQ
Shares Held
320,000
+8.5% QoQ
Ownership
0.478%
of shares outstanding
% of Portfolio
1.62%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Monashee Investment Management LLC holds $22,073,925 across 9 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLDB |
Solid Biosciences Inc.
|
500,000 | $4,995,000 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
50,000 | $4,439,000 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
100,000 | $3,126,000 | |
| 4 | LEGN |
Legend Biotech Corp
|
85,385 | $2,465,918 | |
| 5 | QURE |
uniQure N.V.
|
45,000 | $2,072,700 | |
| 6 | MLTX |
MoonLake Immunotherapeutics
|
75,000 | $1,460,250 | |
| 7 | TSHA |
Taysha Gene Therapies, Inc.
|
200,000 | $1,362,000 | |
| 8 | IMA |
ImageneBio, Inc.
|
192,344 | $1,134,829 |
All Filings in ENGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,179,200 | 320,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,663,850 | 295,000 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||